amoxicillin without a prescription drugs
Conglomerates Stocks

Honeywell International Inc. Analysis – July 2015 Update $HON

honeywell_logoHoneywell International Inc. (HON) has shown strong earnings growth over the last several years and pays a healthy dividend, factors that immediately attracts some investors. In addition, some analysts believe the company to be a good value based on qualitative factors. For example, Seeking Alpha contributor Josh Arnold wrote recently that the company’s growth in margins are making up for lack of sales growth, a position similarly reported by Stephen Simpson. These qualitative issues are excellent to consider in the final stages of an investment decision, but first one must use quantitative metrics to determine the company’s intrinsic value.

Benjamin Graham, the father of value investing, taught that the most important aspect to consider is whether the company is trading at a discount relative to its intrinsic value. It is through a thorough fundamental analysis that the investor is able to make a determination about a potential investment’s merits.

The model is inspired by the teachings of Benjamin Graham and considers numerous metrics intended to help the investor reduce risk levels. The first part of the analysis is to determine whether the company is suitable for the very conservative Defensive Investor or the less conservative Enterprising Investor, who is willing to spend a greater amount of time conducting further research.

In addition, Graham strongly suggested that investors avoid speculation in order to remove the subjective elements of emotion. This is best achieved by utilizing a systematic approach to analysis that will provide investors with a sense of how a specific company compares to another. By using theModernGraham method, one can review a company’s historical accomplishments and determine an intrinsic value that can be compared across industries.

To read the rest of this valuation, you must be logged in as a premium member. If you are not a premium member, please consider becoming one.

Defensive Investor – Must pass at least six of the following seven tests: Score = 4/7

  1. Adequate Size of Enterprise – Market capitalization of at least $2 billion – PASS
  2. Sufficiently Strong Financial Condition – Current ratio greater than 2 – FAIL
  3. Earnings Stability – Positive earnings per share for at least 10 straight years – PASS
  4. Dividend Record – Has paid a dividend for at least 10 straight years – PASS
  5. Earnings Growth – Earnings per share has increased by at least 1/3rd over the last 10 years, using 3-year averages at the beginning and end of the period – PASS
  6. Moderate PEmg (price over normalized earnings) ratio – PEmg is less than 20 – FAIL
  7. Moderate Price to Assets – PB ratio is less than 2.5 or PB x PEmg is less than 50 – FAIL

Enterprising Investor – Must pass at least four of the following five tests or be suitable for a Defensive Investor: Score = 4/5

  1. Sufficiently Strong Financial Condition, Part 1 – Current ratio greater than 1.5 – FAIL
  2. Sufficiently Strong Financial Condition, Part 2 – Debt-to-Net Current Assets ratio less than 1.1 – PASS
  3. Earnings Stability – Positive earnings per share for at least 5 years – PASS
  4. Dividend Record – Currently pays a dividend – PASS
  5. Earnings growth – EPSmg greater than 5 years ago – PASS

Valuation Summary

Key Data

Recent Price $103.36
MG Value $180.11
MG Opinion Undervalued
Value Based on 3% Growth $73.78
Value Based on 0% Growth $43.25
Market Implied Growth Rate 5.91%
Net Current Asset Value (NCAV) -$6.10
PEmg 20.31
Current Ratio 1.49
PB Ratio 4.39

Balance Sheet – March 2015

Current Assets $23,180,000,000
Current Liabilities $15,574,000,000
Total Debt $5,562,000,000
Total Assets $46,412,000,000
Intangible Assets $14,904,000,000
Total Liabilities $27,955,000,000
Outstanding Shares 783,300,000

Earnings Per Share

2015 (estimate) $6.05
2014 $5.33
2013 $4.92
2012 $3.69
2011 $2.61
2010 $2.59
2009 $2.05
2008 $3.76
2007 $3.16
2006 $2.52
2005 $1.92

Earnings Per Share – ModernGraham

2015 (estimate) $5.09
2014 $4.35
2013 $3.63
2012 $2.97
2011 $2.68
2010 $2.75

Dividend History

Free Cash Flow


Honeywell International is not suitable for Defensive Investors but it does pass the initial requirements of the Enterprising Investor. The Defensive Investor is concerned with the low current ratio and the high PEmg and PB ratios, while the Enterprising Investor’s only concern is the low current ratio. As a result, all Enterprising Investors should feel very comfortable proceeding to the next part of the analysis, which is a determination of the company’s intrinsic value.

When it comes to that valuation, it is critical to consider the company’s earnings history. In this case, it has grown its EPSmg (normalized earnings) from $2.68 in 2011 to an estimated $5.09 for 2015. This is a fairly strong level of demonstrated growth and outpaces the market’s implied estimate for annual earnings growth of 5.91% over the next 7-10 years.

In recent years, the company’s actual growth in EPSmg has averaged nearly 18% annually, and while the ModernGraham valuation model reduces the actual growth to a more conservative figure when making an estimate, the model still returns an estimate of intrinsic value well above the current price, indicating that Honeywell International is significantly undervalued at the present time.

Disclaimer:  The author did not hold a position in any company mentioned in this article at the time of publication and had no intention of changing that position within the next 72 hours.  Logo taken from Wikipedia for the sole purpose of identifying the company; this article is not affiliated with the company in any manner.


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back To Top